Clinical Trials & Emerging Therapies in Polycystic Kidney Disease
Polycystic Kidney Disease (PKD) trials explore therapies like vasopressin receptor antagonists, gene editing, and anti-fibrotic agents to slow cyst growth and preserve kidney function. Innovations in regenerative medicine and precision treatments aim to improve kidney health and outcomes.